Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2021

01-04-2021 | Magnetic Resonance Imaging | Case Report

Surgically resected hepatic mass caused by fascioliasis

Authors: Huanlin Wang, Shinji Itoh, Yuji Matsumoto, Akihiro Nishie, Takeshi Kurihara, Tomonari Shimagaki, Yoshihiro Nagao, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Kousei Ishigami, Haruhiko Maruyama, Tomoharu Yoshizumi, Masaki Mori

Published in: Clinical Journal of Gastroenterology | Issue 2/2021

Login to get access

Abstract

Fascioliasis is a parasitic infestation caused by the digenetic trematodes Fasciola hepatica and F. gigantica. It is not commonly seen in developed countries, so diagnosis there is always difficult as a result of confusion with other hepatic or biliary disorders. A 56-year-old man presented at our hospital with a hepatic mass that had been inadvertently discovered by ultrasonography. Abdominal computed tomography revealed a multi-cystic lesion distributed along the branch of the right bile duct. Endoscopic retrograde cholangiopancreatography showed serrated changes ranging from the upper level of the common bile duct to the right hepatic bile duct. Eosinophilia was not observed and tumor marker levels were within normal ranges. Following right lobectomy combined with bile duct reconstruction, a histological examination revealed cholangitis with inflammatory cell infiltration accompanied by parasite egg-like structures and Charcot–Leyden crystals. An additional serologic test was positive for F. hepatica antibodies. A diagnosis of fascioliasis was thus confirmed by histopathology and serology. Fascioliasis should be suspected if imaging findings such as multiple small hypodense lesions in the liver are observed, and serologic tests can be useful for differential diagnosis.
Literature
1.
go back to reference Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol. 2019;1154:71–103.CrossRef Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol. 2019;1154:71–103.CrossRef
2.
go back to reference Haseeb AN, el-Shazly AM, Arafa MA, et al. A review on fascioliasis in Egypt. J Egypt Soc Parasitol. 2002;32:317–54.PubMed Haseeb AN, el-Shazly AM, Arafa MA, et al. A review on fascioliasis in Egypt. J Egypt Soc Parasitol. 2002;32:317–54.PubMed
3.
go back to reference Masoma S, Valero MA, Bargues MD. Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009;69:41–146.CrossRef Masoma S, Valero MA, Bargues MD. Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009;69:41–146.CrossRef
4.
go back to reference Kabaalioglu A, Ceken K, Alimoglu E, et al. Hepatobiliary fascioliasis: sonographic and CT findings in 87 patients during the initial phase and long-term follow-up. AJR Am J Roentgenol. 2007;189:824–8.CrossRef Kabaalioglu A, Ceken K, Alimoglu E, et al. Hepatobiliary fascioliasis: sonographic and CT findings in 87 patients during the initial phase and long-term follow-up. AJR Am J Roentgenol. 2007;189:824–8.CrossRef
5.
go back to reference Chai JY, Jung BK. Epidemiology of trematode infections: an update. Adv Exp Med Biol. 2019;1154:359–409.CrossRef Chai JY, Jung BK. Epidemiology of trematode infections: an update. Adv Exp Med Biol. 2019;1154:359–409.CrossRef
6.
go back to reference Weisenberg SA, Perlada DE. Domestically acquired fascioliasis in northern California. Am J Trop Med Hyg. 2013;89:588–91.CrossRef Weisenberg SA, Perlada DE. Domestically acquired fascioliasis in northern California. Am J Trop Med Hyg. 2013;89:588–91.CrossRef
7.
go back to reference Sivagnanam S, van der Poorten D, Douglas MW. Hepatic lesions and eosinophilia in an urban dweller. Liver Int. 2014;34:643.CrossRef Sivagnanam S, van der Poorten D, Douglas MW. Hepatic lesions and eosinophilia in an urban dweller. Liver Int. 2014;34:643.CrossRef
8.
go back to reference Adachi S, Kotani K, Shimizu T, et al. Asymptomatic fascioliasis. Intern Med. 2005;44:1013–5.CrossRef Adachi S, Kotani K, Shimizu T, et al. Asymptomatic fascioliasis. Intern Med. 2005;44:1013–5.CrossRef
9.
go back to reference Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev. 2009;22:466–83.CrossRef Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev. 2009;22:466–83.CrossRef
10.
go back to reference Chan CW, Lam SK. Diseases caused by liver flukes and cholangiocarcinoma. Baillieres Clin Gastroenterol. 1987;1:297–318.CrossRef Chan CW, Lam SK. Diseases caused by liver flukes and cholangiocarcinoma. Baillieres Clin Gastroenterol. 1987;1:297–318.CrossRef
11.
go back to reference Marcos LA, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis. 2008;21:523–30.CrossRef Marcos LA, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis. 2008;21:523–30.CrossRef
12.
go back to reference Sezgın O, Altintas E, Tombak A, et al. Fasciola hepatica-induced acute pancreatitis: report of two cases and review of the literature. Turk J Gastroenterol. 2010;21:183–7.CrossRef Sezgın O, Altintas E, Tombak A, et al. Fasciola hepatica-induced acute pancreatitis: report of two cases and review of the literature. Turk J Gastroenterol. 2010;21:183–7.CrossRef
13.
go back to reference Kaya M, Beştaş R, Cetin S. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol. 2011;17:4899–904.CrossRef Kaya M, Beştaş R, Cetin S. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol. 2011;17:4899–904.CrossRef
14.
go back to reference Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005;35:1255–78.CrossRef Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005;35:1255–78.CrossRef
15.
go back to reference Cevikol C, Karaali K, Senol U, et al. Human fascioliasis: MR imaging findings of hepatic lesions. Eur Radiol. 2003;13:141–8.CrossRef Cevikol C, Karaali K, Senol U, et al. Human fascioliasis: MR imaging findings of hepatic lesions. Eur Radiol. 2003;13:141–8.CrossRef
16.
go back to reference Koç Z, Ulusan S, Tokmak N. Hepatobiliary fascioliasis: imaging characteristics with a new finding. Diagn Interv Radiol. 2009;15:247–51.PubMed Koç Z, Ulusan S, Tokmak N. Hepatobiliary fascioliasis: imaging characteristics with a new finding. Diagn Interv Radiol. 2009;15:247–51.PubMed
17.
go back to reference Teke M, Önder H, Çiçek M, et al. Sonographic findings of hepatobiliary fascioliasis accompanied by extrahepatic expansion and ectopic lesions. J Ultrasound Med. 2014;33:2105–11.CrossRef Teke M, Önder H, Çiçek M, et al. Sonographic findings of hepatobiliary fascioliasis accompanied by extrahepatic expansion and ectopic lesions. J Ultrasound Med. 2014;33:2105–11.CrossRef
18.
go back to reference Dias LM, Silva R, Viana HL, et al. Biliary fascioliasis: diagnosis, treatment and follow-up by ERCP. Gastrointest Endosc. 1996;43:616–20.CrossRef Dias LM, Silva R, Viana HL, et al. Biliary fascioliasis: diagnosis, treatment and follow-up by ERCP. Gastrointest Endosc. 1996;43:616–20.CrossRef
19.
go back to reference Marcos LA, Tagle M, Terashima A, et al. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg. 2008;78:222–7.CrossRef Marcos LA, Tagle M, Terashima A, et al. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg. 2008;78:222–7.CrossRef
Metadata
Title
Surgically resected hepatic mass caused by fascioliasis
Authors
Huanlin Wang
Shinji Itoh
Yuji Matsumoto
Akihiro Nishie
Takeshi Kurihara
Tomonari Shimagaki
Yoshihiro Nagao
Takeo Toshima
Noboru Harada
Kenichi Kohashi
Yoshinao Oda
Kousei Ishigami
Haruhiko Maruyama
Tomoharu Yoshizumi
Masaki Mori
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01339-0

Other articles of this Issue 2/2021

Clinical Journal of Gastroenterology 2/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.